Leverkusen, Germany

Michael Ostendorf

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Ostendorf. Retrieved from https://idiyas.com/inventor/michael-ostendorf-ktorn891

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Ostendorf: Innovator in Pharmaceutical Formulations

Introduction

Michael Ostendorf is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative processes.

Latest Patents

Ostendorf holds a patent for a process for producing a pharmaceutical formulation that comprises an active substance, polymer, and surfactant. This process involves suspending a pharmaceutical active substance in an aqueous solution of a polymer and drying the mixture obtained. The pharmaceutical active substance is present in the form of particles with a size distribution of ≤1 μm, and before the drying step, it is further contacted with an ionic surfactant. This innovative approach enhances the effectiveness of pharmaceutical formulations.

Career Highlights

Michael Ostendorf is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on developing advanced pharmaceutical solutions that meet the needs of modern medicine.

Collaborations

Ostendorf has collaborated with notable colleagues, including Werner Hoheisel and Bjoern Duesenberg. These collaborations have contributed to the advancement of research and development in the pharmaceutical field.

Conclusion

Michael Ostendorf's contributions to pharmaceutical formulations through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…